馳宏鋅鍺(600497.SH)捐贈750萬元支持新型冠狀病毒肺炎疫情防控
格隆匯3月18日丨馳宏鋅鍺(600497.SH)公佈,為抗擊新型冠狀病毒肺炎疫情,助力黨和國家打贏疫情防控阻擊戰,公司在做好自身疫情防控、實現有序復產及正常生產經營的同時,積極履行企業社會責任。經公司第七屆董事會第二次(臨時)會議審議通過,同意公司以自有資金向湖北省黃石市陽新縣捐贈750萬元,用於其新型冠狀病毒肺炎疫情的防控工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.